# Metabolic Activation With Almased for Type 2 Diabetes Patients

> **NCT01680926** · EARLY_PHASE1 · COMPLETED · sponsor: **West German Center of Diabetes and Health** · enrollment: 22 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DIETARY_SUPPLEMENT:** Almased

## Key facts

- **NCT ID:** NCT01680926
- **Lead sponsor:** West German Center of Diabetes and Health
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2011-02
- **Final completion:** 2011-10
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2012-09-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01680926

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01680926, "Metabolic Activation With Almased for Type 2 Diabetes Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01680926. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*